Ajax Therapeutics, Inc. announced it raised $37.4 Million in an initial filing from an offering of $40 Million
Ajax Therapeutics, Inc. announced it raised $37.4 Million in an initial filing from an offering of $40 Million
06/01/21, 8:30 PM
Location
Money raised
$37.4 million
Industry
biotechnology
Company Info
Location
275 madison ave, 39th floor
new york, new york, united states
Additional Info
Ajax Therapeutics, Inc. is pursuing uniquely selective approaches to develop novel next generation therapies for myeloproliferative neoplasms (MPNs), including myelofibrosis. By combining the deep cancer and structural biology insights of our founding scientists with the industry’s most advanced computational drug discovery and protein structure platforms, we aim to discover and develop more precisely designed therapies to address the significant unmet needs for patients with MPNs.